COVID-19

RUSH-led study offers insight into how lingering symptoms differ by virus variant

Researchers across RUSH University found a correlation between inflammatory bulk IgG glycans and COVID-19 severity

RUSH researchers find virus’ spike protein reduces lung tumors in lab study

'RUSH gave us hope, and a chance, and that assurance was priceless'

A severe case of COVID-19 leads to a life-saving lung cancer diagnosis

A RUSH physician-researcher explains the latest findings and what scientists still aim to discover

Diagnostic tool may lead to delayed, missed treatment for severe COVID-19

A Rush infectious disease expert offers her perspective on the virus

Using social media to connect with higher-risk, harder-to-reach Chicagoans

Benefits, side effects and more about this increasingly common COVID-19 treatment